The INCLIVA Health Research Institute hosted TERRETA, a forum uniting researchers, clinicians, and patients to advance treatments for rare genetic diseases caused by repeat expansions. The...
Incliva participates in the $6.2 million (€5.2 million) European Rebecca project to address the post-treatment of breast cancer. The project will end in March 2025 and...